Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Amortization - Intangibles (2016 - 2019)

Plus Therapeutics has reported Amortization - Intangibles over the past 4 years, most recently at $306000.0 for Q1 2019.

  • Quarterly Amortization - Intangibles changed 0.0% to $306000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2019, changed 0.0% year-over-year, with the annual reading at $1.2 million for FY2018, 0.0% changed from the prior year.
  • Amortization - Intangibles was $306000.0 for Q1 2019 at Plus Therapeutics, roughly flat from $306000.0 in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $308000.0 in Q4 2016 and troughed at $57000.0 in Q3 2016.
  • The 4-year median for Amortization - Intangibles is $306000.0 (2017), against an average of $253846.2.
  • The largest YoY upside for Amortization - Intangibles was 436.84% in 2017 against a maximum downside of 0.65% in 2017.
  • A 4-year view of Amortization - Intangibles shows it stood at $308000.0 in 2016, then dropped by 0.65% to $306000.0 in 2017, then changed by 0.0% to $306000.0 in 2018, then changed by 0.0% to $306000.0 in 2019.
  • Per Business Quant, the three most recent readings for PSTV's Amortization - Intangibles are $306000.0 (Q1 2019), $306000.0 (Q4 2018), and $306000.0 (Q3 2018).